CLINICAL_TRIALS
trial_result
· 2009-09-03
Clinical Trial Update: A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring [Phase 3]
Summary
Phase 3 trial evaluating milnacipran's effects on 24-hour ambulatory blood pressure in fibromyalgia patients, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2009-09-03